Научные статьиM.H.Sayidova, S.U.Pulatova2025
THE EFFECTIVENESS OF NOOTROPIC THERAPY IN PATIENTS WITH RHEUMATIC DISEASES: A CLINICAL ANALYSIS
Khamrayev Khamza Khamidullayevich · Khamraev Botirjon
Современное образование и развитие · 2025
Аннотация
Background: Rheumatic diseases are often accompanied not only by systemic inflammation and joint dysfunction but also by neuropsychiatric symptoms such as cognitive impairment, chronic fatigue, and mood disorders. These manifestations may significantly reduce patients' quality of life and complicate disease management. Objective: This study aims to evaluate the clinical effectiveness of nootropic therapy in patients with various rheumatic diseases and to assess its impact on cognitive function and overall disease course. Methods: A cohort of patients diagnosed with rheumatoid arthritis, systemic lupus erythematosus, and ankylosing spondylitis was observed. Nootropic agents such as piracetam, citicoline, and phenibut were administered as adjunctive therapy over a 12-week period. Clinical parameters, cognitive test scores, and patient-reported outcomes were analyzed before and after intervention. Results: The use of nootropic therapy led to statistically significant improvements in cognitive performance, particularly in memory, attention, and mental processing speed. Additionally, patients reported reduced fatigue and improved emotional stability. No severe adverse effects were observed during the course of treatment. Conclusion: Nootropic agents may represent a promising adjunctive approach in the management of rheumatic diseases, particularly in addressing cognitive and neuropsychiatric comorbidities. Further randomized controlled trials are warranted to confirm these findings and determine long-term efficacy and safety. Выпуск журнала №-23 Часть–4_ Апрель –2025 384 MODERN EDUCATION AND DEVELOPMENT Keywords: rheumatic diseases, nootropic therapy, cognitive impairment, neuropsychiatric symptoms, piracetam, citicoline
Доказательный фрагмент
«Background: Rheumatic diseases are often accompanied not only by systemic inflammation and joint dysfunction but also by neuropsychiatric symptoms such as cognitive impairment, chronic fatigue, and mood disorders.»
Образец извлечения
Демо-превьюBackground: Rheumatic diseases are often accompanied not only by systemic inflammation and joint dysfunction but also by neuropsychiatric symptoms such as cognitive impairment, chronic fatigue, and mood disorders. Полный текст публикации CiteX не хранит — доступ к первоисточнику открывается по DOI согласно лицензии издателя и выбранному плану.
- Цитирований
- 0
- Просмотров
- 0
- Тип
- Журнал
- Страна
- Узбекистан
- Ключевые слова
- rheumatic diseases, nootropic therapy, cognitive impairment
Смежные источники
Общество и инновацииKhosiyat MAMATKULOVA2024
Академические исследования в современной наукеKhudaiberdiyeva Arafat Israilovna, Ph.D Professor hudayberdiyevaarofat@gmail.com +12026
Научные статьиI.B.Yangiboyev, E.X.Berdanov +22025